ACE and Hypertension: Evidence-based medicine accepts the treatment of individuals with DN by the control of high blood sugar and hypertension, and therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), which can slow or halt the progression of diabetic renal disease in early stages.